Charles River Laboratories International, Inc. (NYSE:CRL) Baird 2025 Global Healthcare Conference September 10, 2025 9:40 AM EDT
Company Participants
James Foster – Chairman, President & CEO
Conference Call Participants
Eric Coldwell – Robert W. Baird & Co. Incorporated, Research Division
Presentation
Eric Coldwell
Senior Research Analyst
Good morning, everyone. My name is Eric Coldwell. I cover pharma services, health care distribution at Baird, and it’s a great pleasure to have Charles River with us today. Jim and I have spent a lot of days together over many years, and we’ve seen the ups and downs of this space, but I’m very excited always to have a good conversation with Jim. We have a lot of fun on stage. So hopefully, we can keep that going.
James Foster
Chairman, President & CEO
Always a pleasure.
Eric Coldwell
Senior Research Analyst
And of course, we have support from Todd here in the audience as well. So I couldn’t convince him to jump on stage with me today.
Question-and-Answer Session
Eric Coldwell
Robert W. Baird & Co. Incorporated, Research Division
]
Jim, I’m going to have to ask the obligatory, boring, bad question, which you can’t answer, but you are in a strategic review. You have obviously had some news and noise this year with, let’s call it, a partner on the investment side. What — you mentioned this yesterday. I have to ask for my audience. Tell us the latest and greatest, what you’re thinking on time frame when we might hear something. Maybe step back a little and talk about how you always are under a review, whether or not it’s formal, you’re always thinking about these things.
James Foster
Chairman, President & CEO
So we’re deep in the midst of the strategic review. We are working with some urgency and at a, I
Read the full article here
